Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Ocugen, Inc. (NASDAQ: OCGN) has announced the completion of dosing in the Phase 2 portion of its ArMaDa clinical trial for ...